We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $4.11B
1-Year Est. Return 26.03%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+26.03%
3 Year Est. Return
+55.81%
5 Year Est. Return
+76.4%
10 Year Est. Return
+190.66%
AUM
$8.22B
AUM Growth
+$272M
Cap. Flow
-$1.22B
Cap. Flow %
-14.9%
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$64.1M
2
META icon
Meta Platforms (Facebook)
META
+$58.9M
3
MON
Monsanto Co
MON
+$54.7M
4
CELG
Celgene Corp
CELG
+$53.6M
5
TGT icon
Target
TGT
+$52.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 45.09%
2 Consumer Staples 9.92%
3 Healthcare 9.5%
4 Technology 7.01%
5 Consumer Discretionary 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPO icon
701
Enpro
NPO
$6.08B
$432K 0.01%
+5,901
New +$425K
WDAY icon
702
Workday
WDAY
$45.3B
$431K 0.01%
+4,800
New +$378K
RLYP
703
DELISTED
RELYPSA INC COM
RLYP
$431K 0.01%
+17,724
New +$420K
PLL
704
DELISTED
PALL CORP
PLL
$427K 0.01%
+5,000
New +$428K
ALEX
705
DELISTED
Alexander & Baldwin
ALEX
$426K 0.01%
+10,289
New +$405K
SIAL
706
PUT
DELISTED
SIGMA - ALDRICH CORP
SIAL
$426K 0.01%
4,200
+1,300
+45% +$126K
AOL
707
CALL
DELISTED
AOL INC COMMON STOCK
AOL
$426K 0.01%
10,700
-13,200
-55% -$520K
GRPN icon
708
PUT
Groupon
GRPN
$786M
$423K 0.01%
+3,195
New +$421K
XOOM
709
CALL
DELISTED
XOOM CORP COM
XOOM
$422K 0.01%
+16,000
New +$356K
PMC
710
DELISTED
PharMerica Corporation
PMC
$420K 0.01%
+14,687
New +$409K
PNY
711
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$417K 0.01%
+11,136
New +$398K
AMGN icon
712
CALL
Amgen
AMGN
$203B
$414K 0.01%
3,500
-8,100
-70% -$938K
QVCGA
713
DELISTED
QVC Group Inc Series A
QVCGA
$413K 0.01%
+343
New +$409K
MMYT icon
714
PUT
MakeMyTrip
MMYT
$4.5B
$411K 0.01%
+11,700
New +$297K
TRN icon
715
CALL
Trinity Industries
TRN
$2.26B
$411K 0.01%
13,057
-43,892
-77% -$1.24M
NVRI icon
716
Enviri
NVRI
$578M
$410K 0.01%
15,420
+6,687
+77% +$171K
OME
717
DELISTED
Omega Protein
OME
$408K 0.01%
29,833
+8,896
+42% +$116K
EXAM
718
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$408K 0.01%
+12,846
New +$421K
IONS icon
719
PUT
Ionis Pharmaceuticals
IONS
$7.45B
$406K ﹤0.01%
+11,800
New +$372K
TXTR
720
CALL
DELISTED
TEXTURA CORPORATION COM
TXTR
$404K ﹤0.01%
+17,100
New +$348K
BEAT
721
DELISTED
BioTelemetry, Inc.
BEAT
$404K ﹤0.01%
56,384
-16,519
-23% -$131K
ESS icon
722
Essex Property Trust
ESS
$17.4B
$403K ﹤0.01%
+2,181
New +$386K
ODP
723
DELISTED
ODP
ODP
$401K ﹤0.01%
+7,056
New +$344K
OWW
724
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$401K ﹤0.01%
+45,097
New +$348K
EDE
725
DELISTED
Empire District Electric
EDE
$401K ﹤0.01%
+15,599
New +$378K

Similar funds

Highbridge Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Highbridge Capital Management withdrew a net $1.22B in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.

  • Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
  • Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
  • Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
  • Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
  • Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
  • Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
  • Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.

Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.